Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study (Q43787674)
Jump to navigation
Jump to search
scientific article published in August 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study |
scientific article published in August 2005 |
Statements
1 reference
Effect of angiotensin-converting enzyme or vasopeptidase inhibition on ventricular size and function in patients with heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) echocardiographic study (English)
1 reference
1 reference
Scott D Solomon
1 reference
Mikhail Bourgoun
1 reference
James Fang
1 reference
Jalal K Ghali
1 reference
Michel Martelet
1 reference
Dariusz Wojciechowski
1 reference
Baiba Ansmite
1 reference
Janis Skards
1 reference
Toivo Laks
1 reference
David Henry
1 reference
Milton Packer
1 reference
Marc A Pfeffer
1 reference
OVERTURE Investigators
1 reference
1 August 2005
1 reference
1 reference
Identifiers
1 reference